DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 58501 - 58525 of 62743 in total
Disease ID Disease Name Gene Symbol ▲ Gene ID Gene Name UniProt ID
C0699885 Carcinoma of bladder ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C4721610 Carcinoma, Ovarian Epithelial ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0005695 Bladder Neoplasm ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C1140680 Malignant neoplasm of ovary ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0600139 Prostate carcinoma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0279671 Cervical Squamous Cell Carcinoma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0023473 Myeloid Leukemia, Chronic ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0553723 Squamous cell carcinoma of skin ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0036421 Systemic Scleroderma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0279702 Conventional (Clear Cell) Renal Cell Carcinoma ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C0086651 Mucopolysaccharidosis, MPS-IV-A ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C3160718 PARKINSON DISEASE, LATE-ONSET ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C0007134 Renal Cell Carcinoma ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C2239176 Liver carcinoma ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0037769 West Syndrome ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C3714756 Intellectual Disability ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0279671 Cervical Squamous Cell Carcinoma ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0033999 Pterygium ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0520947 Clumsiness - motor delay ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0302592 Cervix carcinoma ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0008489 Chorea ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0011581 Depressive disorder ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C1970200 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12 ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C4048328 cervical cancer ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203
C0699791 Stomach Carcinoma ST3GAL3 6487 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 Q11203

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024